US-Israel Cross-Border

Brian Goldstein, John Meltaus, Bob Jahrling, David Brown, Bill Asher, Larry Naughton, Karen Copenhaver

Leader in Venture Capital

Extensive representation of leading venture capital firms with increasing international focus.  Representative firms include:

Advent International
Atlas Venture Fund
Battery Ventures
Bessemer Venture Partners
BioVentures Investors
Cardinal Health Partners    
Fairhaven Capital
Flybridge Venture Capital
General Catalyst Partners
Globespan Capital Partners
Greylock Partners
Highland Capital Partners    
Israel Cleantech Ventures
North Bridge Venture Partners
Polaris Ventures
Rockport Venture Partners
Summit Partners

Preeminent Private Equity Practice

Preeminent practice with over $30 billion in middle-market private equity transactions in past five years.  Representative firms include:

Avista Capital Partners
Braemar Energy Ventures
BV Investment Partners
Capital Resource Partners    
Century Capital
JMH Capital
Mainsail Partners
Pluribus Capital Partners    
RFE Investment Partners
Riverside Partners
Spectrum Equity
Windjammer Capital

Experienced in US Public Offerings

Lawyers active in IPO market including representation of blue chip investment bankers and underwriters in public securities offerings with proceeds over $18 billion since 2000, including:

Bank of America Merrill Lynch
Canaccord Genuity
Deutsche Bank
JP Morgan Chase
Morgan Stanley
Needham & Co.
SG Cowen Securities
Stifel Nicolaus Weisel
UBS Securities
William Blair


US-Israel cross-border

Sophisticated US-Israel Cross-Border Practice

Choate lawyers have a long history representing Israeli-related companies and investors dating back to Scitex in 1980s.  Representative recent engagements, include:

  • ValueClick acquisition of Dotomi
  • Summit Partners investment in PeerApp
  • Battery Ventures investment in Anobit Technologies
  • Broadview Ventures investment in Vascular Graft Solutions Ltd.
  • US counsel to WorkLight in acquisition by IBM
  • Battery Ventures investment in Anobit Technologies
  • Globespan Capital Partners investment in Provigent
  • EMC acquisition of ProActivity
  • Israel Cleantech Ventures investment in FRX Polymers
  • Hydro Electro Ventures collaboration with Yissum Research Development of Hebrew University of Jerusalem
  • Foreign associate work with Israeli law firms regarding patent and IP matters
  • Strategic advice regarding open source for Israeli-based VC-backed company

Recognized for Excellence

National and international recognition for excellence, including:

  • Ranked among top “Most Active Law Firms” worldwide based on number of private equity and venture capital deals negotiated and closed in 2012 (Private Equity Analyst)
  • Ranked among top “Most Active Law Firms” worldwide based on number of private equity and venture capital funds worked on that closed in 2012 (Private Equity Analyst
  • Ranked nationally among top US law firms for Venture Capital/Emerging Companies and Middle-Market M&A (The Legal 500)
  • Choate partners named World’s Leading Patent Litigators (Intellectual Asset Magazine)
  • Lawyers recognized for excellence in majority of practice areas (Chambers USA)
  • Over half of equity partners recognized as Best Lawyers (Best Lawyers in America)

Highly Experienced in Cross-Border M&A

Extensive representation of sellers, acquirers, financing sources and investment bankers in public and private mergers and acquisitions, including cross-border transactions.  Nearly 500 transactions with proceeds over $55 billion since 2000.

IP – Maximizing Value

Patent lawyers, patent agents and staff scientists with PhDs and other advanced degrees perform cutting edge work and strategic planning in patents, trademarks, copyrights, licensing, trade secrets and unfair competition in technology and life sciences.

Nationally Recognized in IP Litigation

Expert trial lawyers representing leading technology and life science companies across US in complex IP litigation.  Lead trial counsel in:

  • Akamai Technologies, Inc. v. Limelight Technologies, Inc.
  • Dufrense v. Adobe Systems
  • Momenta Pharmaceuticals and Sandoz, Inc. v. Teva
  • Wyeth v. Intervet and Boehringer Ingelheim
  • King Pharmaceuticals and Wyeth v. Teva
  • Polaroid Corporation v. Hewlett-Packard
  • Streamserve v. Hewlett-Packard
  • Polaroid Corporation v. Eastman Kodak Company
  • Becton, Dickinson v. Insulet
  • Iovate Health Sciences v. Allmax Nutrition

Thank you for reaching out to contact Choate. Before you send your message, we wanted to make sure you are aware of the following. Please do not send any confidential information in response to this link. Sending an e-mail to Choate does not give rise to an attorney-client relationship, and will not be deemed to disqualify Choate from undertaking any engagement for a current or future client.  Before any attorney-client engagement may be formed, Choate will need to check for possible conflicts of interest, you will need to consider whether you wish to retain Choate as counsel, and we will need to consider whether we wish to accept the potential engagement. In the meantime, Choate reserves the right to represent parties with interests adverse to you.